Embecta Corp.

EMBC Nasdaq SEC CIK 1872789
Follow Embecta Corp. Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $271.7M −8.1% vs same quarter last year
Net income $21.1M −53.6% vs same quarter last year
EPS, diluted $0.36 −53.8% vs same quarter last year
Operating cash flow $41.8M −48.5% vs same quarter last year
Revenue by quarter
$286.1M
$261.9M
$259M
$295.5M
$264M
$261.2M
$221.8M
$271.7M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income7 fiscal years
  • Revenue
  • Net income
$0$500M$1B$1.5BFY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearRevenueNet income
FY25$1.1B$95.4M
FY24$1.1B$78.3M
FY23$1.1B$70.4M
FY22$1.1B$223.6M
FY21$1.2B$414.8M
FY20$1.1B$427.6M
FY19--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
0%20%40%60%80%FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2562.6%22.4%8.8%
FY2465.5%14.9%7%
FY2366.9%19.8%6.3%
FY2268.6%27.4%19.8%
FY2168.7%42.2%35.6%
FY2070.3%44.8%39.4%
FY19---
Free cash flowOperating cash flow minus capital expenditure
$0$200M$400M$600MFY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearFree cash flow
FY25$182.4M
FY24$19.9M
FY23$41.2M
FY22$388.6M
FY21$419.5M
FY20$456.6M
FY19-
Returned to shareholdersDividends paid and shares bought back
$0$10M$20M$30M$40MFY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearDividends
FY25$35M
FY24$34.5M
FY23$34.4M
FY22$8.6M
FY21$0
FY20$0
FY19-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Embecta Corp.
  • Healthcare median
−100%−50%0%50%FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearEmbecta Corp.Healthcare median
FY258.8%−30.6%
FY247%−47%
FY236.3%−58%
FY2219.8%−80.4%
FY2135.6%−71.9%
FY2039.4%−62.2%
FY19-−46.3%